Arcturus Therapeutics Stock Forecast - Double Exponential Smoothing

ARCT Stock  USD 33.77  0.91  2.77%   
The Double Exponential Smoothing forecasted value of Arcturus Therapeutics Holdings on the next trading day is expected to be 33.65 with a mean absolute deviation of  1.25  and the sum of the absolute errors of 74.79. Arcturus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Arcturus Therapeutics stock prices and determine the direction of Arcturus Therapeutics Holdings's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Arcturus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Arcturus Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Arcturus Therapeutics' systematic risk associated with finding meaningful patterns of Arcturus Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of Arcturus Therapeutics to cross-verify your projections.
  
Fixed Asset Turnover is likely to gain to 5.31 in 2024, whereas Payables Turnover is likely to drop 0.53 in 2024. . Common Stock Shares Outstanding is likely to gain to about 28 M in 2024. Net Income Applicable To Common Shares is likely to gain to about 8.8 M in 2024.

Open Interest Against 2024-04-19 Arcturus Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Arcturus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Arcturus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Arcturus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Arcturus Therapeutics' open interest, investors have to compare it to Arcturus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Arcturus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Arcturus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Arcturus Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Arcturus Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Arcturus Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Arcturus Therapeutics works best with periods where there are trends or seasonality.

Arcturus Therapeutics Double Exponential Smoothing Price Forecast For the 30th of March

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Arcturus Therapeutics Holdings on the next trading day is expected to be 33.65 with a mean absolute deviation of 1.25, mean absolute percentage error of 2.38, and the sum of the absolute errors of 74.79.
Please note that although there have been many attempts to predict Arcturus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Arcturus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Arcturus Therapeutics Stock Forecast Pattern

Backtest Arcturus TherapeuticsArcturus Therapeutics Price PredictionBuy or Sell Advice 

Arcturus Therapeutics Forecasted Value

In the context of forecasting Arcturus Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Arcturus Therapeutics' downside and upside margins for the forecasting period are 29.77 and 37.53, respectively. We have considered Arcturus Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
33.77
33.65
Expected Value
37.53
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Arcturus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Arcturus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.1971
MADMean absolute deviation1.2465
MAPEMean absolute percentage error0.0351
SAESum of the absolute errors74.7907
When Arcturus Therapeutics Holdings prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Arcturus Therapeutics Holdings trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Arcturus Therapeutics observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Arcturus Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcturus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcturus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
29.8933.7737.65
Details
Intrinsic
Valuation
LowRealHigh
25.8929.7737.15
Details
Bollinger
Band Projection (param)
LowMiddleHigh
30.8636.5642.26
Details
10 Analysts
Consensus
LowTargetHigh
49.6054.5060.50
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arcturus Therapeutics. Your research has to be compared to or analyzed against Arcturus Therapeutics' peers to derive any actionable benefits. When done correctly, Arcturus Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Arcturus Therapeutics.

Other Forecasting Options for Arcturus Therapeutics

For every potential investor in Arcturus, whether a beginner or expert, Arcturus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arcturus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arcturus. Basic forecasting techniques help filter out the noise by identifying Arcturus Therapeutics' price trends.

Arcturus Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arcturus Therapeutics stock to make a market-neutral strategy. Peer analysis of Arcturus Therapeutics could also be used in its relative valuation, which is a method of valuing Arcturus Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Arcturus Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Arcturus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Arcturus Therapeutics' current price.

Arcturus Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Arcturus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcturus Therapeutics shares will generate the highest return on investment. By undertsting and applying Arcturus Therapeutics stock market strength indicators, traders can identify Arcturus Therapeutics Holdings entry and exit signals to maximize returns.

Arcturus Therapeutics Risk Indicators

The analysis of Arcturus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arcturus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arcturus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Arcturus Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Arcturus Therapeutics' short interest history, or implied volatility extrapolated from Arcturus Therapeutics options trading.

Pair Trading with Arcturus Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arcturus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Arcturus Stock

  0.64VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.45MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.41MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Arcturus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arcturus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arcturus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arcturus Therapeutics Holdings to buy it.
The correlation of Arcturus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arcturus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arcturus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arcturus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Arcturus Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Arcturus Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Arcturus Therapeutics Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Arcturus Therapeutics Holdings Stock:
Check out Historical Fundamental Analysis of Arcturus Therapeutics to cross-verify your projections.
Note that the Arcturus Therapeutics information on this page should be used as a complementary analysis to other Arcturus Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Arcturus Stock analysis

When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance
Is Arcturus Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcturus Therapeutics. If investors know Arcturus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcturus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.12)
Revenue Per Share
6.264
Quarterly Revenue Growth
(0.81)
Return On Assets
(0.11)
Return On Equity
(0.11)
The market value of Arcturus Therapeutics is measured differently than its book value, which is the value of Arcturus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcturus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Arcturus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcturus Therapeutics' market value can be influenced by many factors that don't directly affect Arcturus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcturus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcturus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcturus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.